)
Edge12 Dec 2025
Running on Clouds: The Story of On
The story of how a Swiss runner's pursuit of a new running sensation became On, aiming to be the most premium global sportswear brand worldwide.
Recce Pharmaceuticals (RCE) investor relations material
Recce Pharmaceuticals AGM 2025 Presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2025 Presentation summary4 Nov, 2025
Opening remarks and agenda
Presented an overview of the company's mission to address antibiotic resistance with novel synthetic anti-infectives and outlined the agenda focused on clinical progress, financials, and strategic initiatives.
Financial performance review
Market capitalisation as of October 2025 was AUD $121.46 million, with a share price of AUD $0.405 and 289.18 million shares on issue.
Secured non-dilutive financing via a debt facility of up to AUD $30 million with Avenue Capital Group.
Received AUD $54.95 million in Advanced Overseas Finding from the Australian Government, extending R&D rebates globally for three years.
Canadian government rebate of US $175,122 received for scientific research and experimental development.
Board and executive committee updates
Board chaired by Dr John Prendergast, with extensive experience in pharmaceutical asset commercialisation and capital raising.
CEO James Graham highlighted for his expertise in global business development and capital raising.
Dr Alan Dunton, Chief Medical Advisor, brings over 30 years of drug development experience, including multiple new drug approvals.
Michele Dilizia, Executive Director & CSO, co-led R&D and global patent portfolio development.
Dr Justin Ward, Executive Director & Principal Quality Chemist, focuses on regulatory compliance and manufacturing standards.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Recce Pharmaceuticals earnings date
H1 202625 Feb, 2026
Next Recce Pharmaceuticals earnings date
H1 202625 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Recce Pharmaceuticals Ltd is an Australian biotechnology company specializing in the development of synthetic anti-infectives to treat serious and hard-to-treat infections. The company’s proprietary technology focuses on creating broad-spectrum antibiotics designed to address antibiotic-resistant bacteria and viral infections. Recce’s primary products target bacterial sepsis, bloodstream infections, and other drug-resistant infections. Its approach to antimicrobial development aims to tackle the global challenge of antibiotic resistance through innovative, synthetic compounds that enhance treatment efficacy. The company is headquartered in Sydney, Australia, and its shares are listed on the ASX.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage